Will Rocket Lab's diluted share count grow by less than 5% in H1 2026?
Current Prediction
Why This Question Matters
ATM dilution volume directly tests whether Rocket Lab can fund operations without excessive shareholder dilution. The $280.6M Q4 ATM raise was substantial. If dilution stays below 5% in H1, it suggests the company can manage through Neutron development without aggressive equity sales. Above 5% would signal persistent funding stress and validate the STRETCHED assessment.
Prediction Distribution
Individual Predictions(9 runs)
At $40+ per share, 5% dilution equals roughly 25M+ shares or $1B+ in ATM proceeds. That far exceeds what Rocket Lab would need in H1 2026 given $1.1B existing cash. Even with SBC and convertible conversions, 5% in 6 months is a high bar. The elevated stock price makes dilution per dollar very efficient.
The $280.6M Q4 ATM at ~$40 per share was approximately 7M shares, or ~1.4% dilution. Even if they repeat that pace for two quarters plus convertible conversions and SBC, total dilution would likely be 4-5%. The 5% threshold is generous enough to make YES more likely than NO.
The key risk is convertible note conversions, which are mechanistic and could accelerate. If a significant tranche converts in H1, combined with ATM sales and SBC, 5% is achievable. But the elevated stock price works in favor of lower dilution per dollar raised. Moderately favorable for staying below 5%.
5% dilution in 6 months is substantial. Even with aggressive ATM usage, the math at $40+ per share makes it hard to exceed 5% through ATM alone. Convertibles and SBC add incrementally but manageable. YES is more likely.
The wildcard is convertible note conversions. If a large tranche converts, it could push dilution above 5% even without aggressive ATM usage. Without knowing the exact conversion schedule, lower confidence. Slightly favorable for below 5%.
Rocket Lab has $1.1B cash and is generating growing revenue. The need for aggressive dilution is lower than in prior years. Management should be aware of dilution sensitivity at the current valuation. Moderately likely to stay below 5%.
At current stock prices, staying below 5% dilution is achievable. The company has alternatives to ATM (SDA milestone payments, revenue growth) that reduce dependence on equity markets.
Moderate confidence that dilution stays below 5%. The main risk is convertible conversions adding to the count. ATM alone unlikely to push above 5% given stock price.
5% is a reasonable threshold. With $1.1B cash and growing revenue, Rocket Lab should be able to manage dilution below this level. Favorable for YES.
Resolution Criteria
Resolves YES if the diluted share count as of Q2 2026 is less than 5% higher than Q4 2025 diluted share count. Resolves NO if diluted share growth is 5% or more.
Resolution Source
Rocket Lab Q2 2026 10-Q filing, diluted shares outstanding
Source Trigger
ATM Dilution Volume — Monitor quarterly share count growth. Significant acceleration in ATM sales at lower prices would signal funding stress
Full multi-lens equity analysis